疼痛管理装置の世界市場2020-2026:製品別(神経調節・神経刺激装置、鎮痛剤注入ポンプ・アブレーション装置)、用途別、地域別

◆英語タイトル:Global Pain Management Devices Market By Product (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices) By Application (Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications) By Region, Industry Analysis and Forecast, 2020 - 2026
◆商品コード:KBV20OCT042
◆発行会社(リサーチ会社):KBV Research
◆発行日:2020年5月31日
◆ページ数:181
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ、カナダ、メキシコ、ロシア、ドイツ、イギリス、フランス、スペイン、イタリア、中国、日本、インド、韓国、シンガポール、マレーシア、ブラジル、アルゼンチン、アラブ首長国連邦、サウジアラビア、南アフリカ、ナイジェリア
◆販売価格オプション(消費税別)
Single User(1名様利用)USD3,600 ⇒換算¥388,800見積依頼/購入/質問フォーム
Global License(法人利用)USD6,048 ⇒換算¥653,184見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はKBV Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
KBV Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本市場調査レポートでは、疼痛管理装置の世界市場について、市場範囲・調査手法、市場概要、競争分析、製品別(神経調節・神経刺激装置、鎮痛剤注入ポンプ・アブレーション装置)分析、用途別分析、地域別分析、企業概要などを総合的、多面的に調査・分析しました。
・市場範囲・調査手法
・市場概要
・競争分析
・疼痛管理装置の世界市場規模:製品別(神経調節・神経刺激装置、鎮痛剤注入ポンプ・アブレーション装置)
・疼痛管理装置の世界市場規模:用途別
・疼痛管理装置の世界市場規模:地域別
・企業概要
【レポートの概要】

The Global Pain Management Devices Market size is expected to reach $6.3 billion by 2026, rising at a market growth of 8.5% CAGR during the forecast period. Pain management is a branch of medical science that relieves patients with chronic pain from their suffering. Acute pain has a sudden onset of action, while chronic pain persists for a longer period of time, which leads to the need for its control. Pain management devices are medical devices used to relieve different forms of pressure such as neuropathic pain, cancer pain, nociceptive pain, musculoskeletal pain among others. Stimulators for the spinal cord, transcutaneous electrical nerve stimulators, analgesic infusion pumps, and ablation devices are different types of pain management devices available on the market.

With Covid-19 infections rising globally, there is also deepening apprehension about a shortage of essential life-saving devices and other essential medical supplies to prevent the spread of this pandemic and provide optimum care to those infected. Additionally, for COVID-19 patients, who may require critical care, ventilators act as a vital treatment preference until a pharmacological treatment is developed. In addition, a wide range of test-kits (antibody tests, self-administered, and others) involves a fast acceleration in the manufacturing phase.

Growth in the global market for pain management devices is driven by the increase in geriatric population, a rise in chronic pain pervasiveness, growing awareness of people’s awareness of pain management devices, improved investment in R&D to develop innovative products and the launch of new products. Additionally, growing demand for pain management devices in emerging countries and increasing the use of pain management devices for chronic pain management are other factors contributing to market growth. In addition, the untapped potential offered by developing economies is presenting lucrative market expansion opportunities over the forecast period. Nevertheless, reactions to hypersensitivity and postoperative infections caused by the use of these devices restrict their adoption, which hampers the market growth.

Based on Product, the market is segmented into Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices. Based on Application, the market is segmented into Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The major strategies followed by the market participants are Partnerships and Acquisition. Based on the Analysis presented in the Cardinal matrix, Johnson and Johnson and Pfizer, Inc. are the forerunners in the Pain Management Devices Market. Companies such as Boston Scientific Corporation, Medtronic PLC, Colfax Corporation, Stryker Corporation, Kimberly-Clark Corporation, and Abbott Laboratories, Baxter International, Inc., and B. Braun Melsungen AG are some of the key innovators in the market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, Kimberly-Clark Corporation, Stryker Corporation, and Colfax Corporation (DJO Global, Inc.)

Recent strategies deployed in Pain Management Devices Market
Partnerships, Collaborations, and Agreements:

May-2020: Medtronic collaborated with UW following which the company has accelerated research into deep brain stimulation treatment for essential tremor, Parkinson’s disease, and other neurological disorders.
May-2019: Abbott came into partnership with the US National Institutes of Health (NIH). The partnership was aimed at developing unique insights and driving the application of neurostimulation therapies. The partnership would provide the latter company’s neuroscience research initiative BRAIN access to Abbott’s neuromodulation technologies.
Approvals:
Jan-2020: Abbott Laboratories got approval from the US Food and Drug Administration (FDA) for its Infinity Deep Brain Stimulation (DBS) system. This system would be used in the treatment of Parkinson’s disease. The system would enable targeting a specific area of the brain known as the internal globus pallidus (GPi) for improving the symptoms of Parkinson’s disease not controlled by medication.
Jan-2020: Medtronic secured a CE Mark for its Percept PC neurostimulator. It is the only deep brain stimulation (DBS) system launched in the EU with BrainSense technology, which senses and records brain signals while delivering DBS therapy to people with neurological disorders such as Parkinson’s disease.
Sep-2019: Abbott announced that the U.S. Food and Drug Administration (FDA) approved its Proclaim XR recharge-free neurostimulation system for people living with chronic pain. The Proclaim XR platform provides a low dose of Abbott’s proprietary BurstDR stimulation waveform, which was created based on scientific insights from doctors and researchers to mimic natural patterns found in the brain. It works by using low doses of mild electrical pulses to change pain signals as they travel from the spinal cord to the brain.
Acquisition and Mergers:
Jan-2020: Medtronic took over Stimgenics, a startup company that has developed a novel spinal cord stimulation waveform. This acquisition enabled the company to expand its business in the SCS Market.
Jun-2019: Boston Scientific acquired Vertiflex, a healthcare company. Through this acquisition, Vertiflex’s spinal cord stimulation and radiofrequency ablation have been added to Boston Scientific’s product portfolio.
Oct-2017: Stryker Corporation took over VEXIM, a medical device company specializing in the minimally invasive treatment of vertebral fractures. Through this acquisition, Stryker enabled the latter company to become a global leader in trauma and expanded its geographical foothold.
Jun-2017: DePuy Synthes Products, Inc., part of the Johnson & Johnson Medical Devices Companies acquired Innovative Surgical Solutions, LLC, doing business as Sentio, LLC, a company that markets innovative nerve localization technology for spine surgery. The acquisition strengthened its spine portfolio in decompression procedures as well as lateral surgery and developed a platform for future innovation in minimally invasive surgery.
Jul-2016: Boston took over Cosman Medical following which Cosman operates under the Boston Scientific Neuromodulation business. Following the acquisition, the company aimed to offer a wide range of spinal cord stimulator (SCS) systems to the patients suffering from chronic pain.
Product Launches and Product Expansions:
Jan-2019: Boston Scientific introduced the Vercise Primary Cell (PC) and Vercise Gevia Deep Brain Stimulation (DBS) Systems. The systems feature the Vercise Cartesia Directional Lead. The systems have the technology that enables the physicians in controlling the range, shape, position, and direction of electrical stimulation to treat the symptoms of Parkinson’s disease (PD) through highly-personalized therapy.
Jan-2019: Boston launched WaveWriter Spinal Cord Stimulator (SCS) System in Europe for providing the treatment of chronic pain to people in Europe.

Scope of the Study
Market Segmentation:

By Product
• Neuromodulation & Neurostimulation Devices
• Analgesic Infusion Pumps and
• Ablation Devices

By Application
• Neuropathic Pain
• Musculoskeletal Pain
• Cancer Pain
• Facial & Migraine Pain and
• Other Applications

By Geography
• North America
o US
o Canada
o Mexico
o Rest of North America
• Europe
o Germany
o UK
o France
o Russia
o Spain
o Italy
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Singapore
o Malaysia
o Rest of Asia Pacific
• LAMEA
o Brazil
o Argentina
o UAE
o Saudi Arabia
o South Africa
o Nigeria
o Rest of LAMEA

Companies Profiled
• Abbott Laboratories
• B. Braun Melsungen AG
• Baxter International, Inc.
• Pfizer, Inc.
• Boston Scientific Corporation
• Johnson and Johnson
• Medtronic PLC
• Kimberly-Clark Corporation
• Stryker Corporation
• Colfax Corporation (DJO Global, Inc.)

Unique Offerings from KBV Research
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

【レポートの目次】

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Pain Management Devices Market, by Product
1.4.2 Global Pain Management Devices Market, by Application
1.4.3 Global Pain Management Devices Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis – Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, Oct – 2020, May) Leading Players
Chapter 4. Global Pain Management Devices Market by Product
4.1 Global Neuromodulation & Neurostimulation Devices Market by Region
4.2 Global Analgesic Infusion Pumps Market by Region
4.3 Global Ablation Devices Market by Region
Chapter 5. Global Pain Management Devices Market by Application
5.1 Global Neuropathic Pain Market by Region
5.2 Global Musculoskeletal Pain Market by Region
5.3 Global Cancer Pain Market by Region
5.4 Global Facial & Migraine Pain Market by Region
5.5 Global Other Applications Market by Region
Chapter 6. Global Pain Management Devices Market by Region
6.1 North America Pain Management Devices Market
6.1.1 North America Pain Management Devices Market by Product
6.1.1.1 North America Neuromodulation & Neurostimulation Devices Market by Country
6.1.1.2 North America Analgesic Infusion Pumps Market by Country
6.1.1.3 North America Ablation Devices Market by Country
6.1.2 North America Pain Management Devices Market by Application
6.1.2.1 North America Neuropathic Pain Market by Country
6.1.2.2 North America Musculoskeletal Pain Market by Country
6.1.2.3 North America Cancer Pain Market by Country
6.1.2.4 North America Facial & Migraine Pain Market by Country
6.1.2.5 North America Other Applications Market by Country
6.1.3 North America Pain Management Devices Market by Country
6.1.3.1 US Pain Management Devices Market
6.1.3.1.1 US Pain Management Devices Market by Product
6.1.3.1.2 US Pain Management Devices Market by Application
6.1.3.2 Canada Pain Management Devices Market
6.1.3.2.1 Canada Pain Management Devices Market by Product
6.1.3.2.2 Canada Pain Management Devices Market by Application
6.1.3.3 Mexico Pain Management Devices Market
6.1.3.3.1 Mexico Pain Management Devices Market by Product
6.1.3.3.2 Mexico Pain Management Devices Market by Application
6.1.3.4 Rest of North America Pain Management Devices Market
6.1.3.4.1 Rest of North America Pain Management Devices Market by Product
6.1.3.4.2 Rest of North America Pain Management Devices Market by Application
6.2 Europe Pain Management Devices Market
6.2.1 Europe Pain Management Devices Market by Product
6.2.1.1 Europe Neuromodulation & Neurostimulation Devices Market by Country
6.2.1.2 Europe Analgesic Infusion Pumps Market by Country
6.2.1.3 Europe Ablation Devices Market by Country
6.2.2 Europe Pain Management Devices Market by Application
6.2.2.1 Europe Neuropathic Pain Market by Country
6.2.2.2 Europe Musculoskeletal Pain Market by Country
6.2.2.3 Europe Cancer Pain Market by Country
6.2.2.4 Europe Facial & Migraine Pain Market by Country
6.2.2.5 Europe Other Applications Market by Country
6.2.3 Europe Pain Management Devices Market by Country
6.2.3.1 Germany Pain Management Devices Market
6.2.3.1.1 Germany Pain Management Devices Market by Product
6.2.3.1.2 Germany Pain Management Devices Market by Application
6.2.3.2 UK Pain Management Devices Market
6.2.3.2.1 UK Pain Management Devices Market by Product
6.2.3.2.2 UK Pain Management Devices Market by Application
6.2.3.3 France Pain Management Devices Market
6.2.3.3.1 France Pain Management Devices Market by Product
6.2.3.3.2 France Pain Management Devices Market by Application
6.2.3.4 Russia Pain Management Devices Market
6.2.3.4.1 Russia Pain Management Devices Market by Product
6.2.3.4.2 Russia Pain Management Devices Market by Application
6.2.3.5 Spain Pain Management Devices Market
6.2.3.5.1 Spain Pain Management Devices Market by Product
6.2.3.5.2 Spain Pain Management Devices Market by Application
6.2.3.6 Italy Pain Management Devices Market
6.2.3.6.1 Italy Pain Management Devices Market by Product
6.2.3.6.2 Italy Pain Management Devices Market by Application
6.2.3.7 Rest of Europe Pain Management Devices Market
6.2.3.7.1 Rest of Europe Pain Management Devices Market by Product
6.2.3.7.2 Rest of Europe Pain Management Devices Market by Application
6.3 Asia Pacific Pain Management Devices Market
6.3.1 Asia Pacific Pain Management Devices Market by Product
6.3.1.1 Asia Pacific Neuromodulation & Neurostimulation Devices Market by Country
6.3.1.2 Asia Pacific Analgesic Infusion Pumps Market by Country
6.3.1.3 Asia Pacific Ablation Devices Market by Country
6.3.2 Asia Pacific Pain Management Devices Market by Application
6.3.2.1 Asia Pacific Neuropathic Pain Market by Country
6.3.2.2 Asia Pacific Musculoskeletal Pain Market by Country
6.3.2.3 Asia Pacific Cancer Pain Market by Country
6.3.2.4 Asia Pacific Facial & Migraine Pain Market by Country
6.3.2.5 Asia Pacific Other Applications Market by Country
6.3.3 Asia Pacific Pain Management Devices Market by Country
6.3.3.1 China Pain Management Devices Market
6.3.3.1.1 China Pain Management Devices Market by Product
6.3.3.1.2 China Pain Management Devices Market by Application
6.3.3.2 Japan Pain Management Devices Market
6.3.3.2.1 Japan Pain Management Devices Market by Product
6.3.3.2.2 Japan Pain Management Devices Market by Application
6.3.3.3 India Pain Management Devices Market
6.3.3.3.1 India Pain Management Devices Market by Product
6.3.3.3.2 India Pain Management Devices Market by Application
6.3.3.4 South Korea Pain Management Devices Market
6.3.3.4.1 South Korea Pain Management Devices Market by Product
6.3.3.4.2 South Korea Pain Management Devices Market by Application
6.3.3.5 Singapore Pain Management Devices Market
6.3.3.5.1 Singapore Pain Management Devices Market by Product
6.3.3.5.2 Singapore Pain Management Devices Market by Application
6.3.3.6 Malaysia Pain Management Devices Market
6.3.3.6.1 Malaysia Pain Management Devices Market by Product
6.3.3.6.2 Malaysia Pain Management Devices Market by Application
6.3.3.7 Rest of Asia Pacific Pain Management Devices Market
6.3.3.7.1 Rest of Asia Pacific Pain Management Devices Market by Product
6.3.3.7.2 Rest of Asia Pacific Pain Management Devices Market by Application
6.4 LAMEA Pain Management Devices Market
6.4.1 LAMEA Pain Management Devices Market by Product
6.4.1.1 LAMEA Neuromodulation & Neurostimulation Devices Market by Country
6.4.1.2 LAMEA Analgesic Infusion Pumps Market by Country
6.4.1.3 LAMEA Ablation Devices Market by Country
6.4.2 LAMEA Pain Management Devices Market by Application
6.4.2.1 LAMEA Neuropathic Pain Market by Country
6.4.2.2 LAMEA Musculoskeletal Pain Market by Country
6.4.2.3 LAMEA Cancer Pain Market by Country
6.4.2.4 LAMEA Facial & Migraine Pain Market by Country
6.4.2.5 LAMEA Other Applications Market by Country
6.4.3 LAMEA Pain Management Devices Market by Country
6.4.3.1 Brazil Pain Management Devices Market
6.4.3.1.1 Brazil Pain Management Devices Market by Product
6.4.3.1.2 Brazil Pain Management Devices Market by Application
6.4.3.2 Argentina Pain Management Devices Market
6.4.3.2.1 Argentina Pain Management Devices Market by Product
6.4.3.2.2 Argentina Pain Management Devices Market by Application
6.4.3.3 UAE Pain Management Devices Market
6.4.3.3.1 UAE Pain Management Devices Market by Product
6.4.3.3.2 UAE Pain Management Devices Market by Application
6.4.3.4 Saudi Arabia Pain Management Devices Market
6.4.3.4.1 Saudi Arabia Pain Management Devices Market by Product
6.4.3.4.2 Saudi Arabia Pain Management Devices Market by Application
6.4.3.5 South Africa Pain Management Devices Market
6.4.3.5.1 South Africa Pain Management Devices Market by Product
6.4.3.5.2 South Africa Pain Management Devices Market by Application
6.4.3.6 Nigeria Pain Management Devices Market
6.4.3.6.1 Nigeria Pain Management Devices Market by Product
6.4.3.6.2 Nigeria Pain Management Devices Market by Application
6.4.3.7 Rest of LAMEA Pain Management Devices Market
6.4.3.7.1 Rest of LAMEA Pain Management Devices Market by Product
6.4.3.7.2 Rest of LAMEA Pain Management Devices Market by Application
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Approvals:
7.2 B. Braun Melsungen AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental Analysis
7.2.4 Research & Development Expense
7.3 Baxter International, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals:
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Boston Scientific Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.5.2 Product Launches and Product Expansions:
7.6 Johnson and Johnson
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental &Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Acquisition and Mergers:
7.7 Medtronic PLC
7.7.1 Company overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 Recent strategies and developments:
7.7.5.1 Partnerships, Collaborations, and Agreements:
7.7.5.2 Approvals:
7.7.5.3 Acquisition and Mergers:
7.7.5.4 Product Launches and Product Expansions:
7.8 Kimberly-Clark Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Stryker Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.1 Colfax Corporation (DJO Global, Inc.)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Product Launches and Product Expansions:



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[疼痛管理装置の世界市場2020-2026:製品別(神経調節・神経刺激装置、鎮痛剤注入ポンプ・アブレーション装置)、用途別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆